Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05175547 · ClinicalTrials.gov registry record · Phase 3
Clevidipine Infusion for Blood Pressure Management After Successful Revascularization in Acute Ischemic Stroke
A Phase 3 study, sponsored by ProMedica Health System.
- Completed
- Registry status
- Phase 3
- Development phase
- 80
- Enrollment target
NCT05175547: Completed Phase 3 study, sponsored by ProMedica Health System.
NCT05175547 is a Phase 3 study that has completed, run by ProMedica Health System. The registered enrollment target is 80 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05175547, a Phase 3 study, has completed, sponsored by ProMedica Health System.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 80 participants
- Enrollment target
Study Summary
The CLEVER Study is a prospective, 2-arm, randomized, single-center pilot study to assess the safety and efficacy of intensive blood pressure control using Clevidipine (on-label use) in AIS patients undergoing standard of care mechanical thrombectomy (MT) within 24-hours of symptoms onset.
Primary Outcome
Time to target blood pressure
Interventions
- DRUG Clevidipine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2021-10-30 |
| Est. Completion | 2024-02-28 |
| Phase | Phase 3 |
What the finished NCT05175547 record still lists
NCT05175547 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which Clevidipine is the first listed.
NCT05175547 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05175547 about?
NCT05175547 is a clinical study titled "Clevidipine Infusion for Blood Pressure Management After Successful Revascularization in Acute Ischemic Stroke". The CLEVER Study is a prospective, 2-arm, randomized, single-center pilot study to assess the safety and efficacy of intensive blood pressure control using Clevidipine (on-label use) in AIS patients undergoing standard of care mechanical thrombectomy (MT) within 24-hours of symptoms onset.
What is the current status of trial NCT05175547?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 80 participants. The study started on 2021-10-30. Estimated completion is 2024-02-28.
What interventions are being tested in trial NCT05175547?
The interventions under investigation include: Clevidipine (DRUG).
Who is sponsoring clinical trial NCT05175547?
This trial is sponsored by ProMedica Health System, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05175547's enrollment target sits among peer trials
80 1755th of 2000 higher than 233 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI